C12N 2840/60
From viruses
Official title: from viruses
C12N2840/60 (From viruses) appears on 38 US grants and 64 published applications in this corpus.
Search patents in C12N- Granted patents
- 38
- Published applications
- 64
- Assignees
- 38
- Inventors
- 129
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 1 |
| 2003 | 2 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 2 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 1 | 2 |
| 2013 | 0 | 2 |
| 2014 | 2 | 3 |
| 2015 | 1 | 3 |
| 2016 | 1 | 2 |
| 2017 | 3 | 4 |
| 2018 | 2 | 2 |
| 2019 | 2 | 2 |
| 2020 | 3 | 3 |
| 2021 | 2 | 9 |
| 2022 | 5 | 5 |
| 2023 | 4 | 3 |
| 2024 | 1 | 3 |
| 2025 | 1 | 6 |
| 2026 | 3 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Regulatable adeno-associated virus (AAV) vector2 Jun 2026US 12,642,869 B2Georg-August-UniversitäT GöTtingen Stiftung öFfentlichen Rechts, UniversitäTsmedizin
- Circular RNA compositions14 Apr 2026US 12,599,679 B2Orna Therapeutics, Inc.
- Circular RNA for translation in eukaryotic cells10 Mar 2026US 12,570,996 B2Massachusetts Institute of Technology
- Circular RNA for translation in eukaryotic cells30 Dec 2025US 12,509,701 B2Massachusetts Institute of Technology
- Circular RNA for translation in eukaryotic cells14 May 2024US 11,981,909 B2Massachusetts Institute of Technology
- Circular rna and preparation method thereof10 Sep 2026US 2026/0265772 A1RiboX Therapeutics HK Limited
- Methods and compositions for conferring cellular resistance to viral infection3 Sep 2026US 2026/0258406 A1President and Fellows of Harvard College
- Compositions and methods for improved protein translation from recombinant circular rnas13 Aug 2026US 2026/0234654 A1The Board of Trustees of the Leland Stanford Junior University
- Recombinant adeno-associated virus vector30 Jul 2026US 2026/0218228 A1Quethera Limited
- Circular RNA For Translation In Eukaryotic Cells30 Apr 2026US 2026/0117252 A1Massachusetts Institute of Technology
Most cited
By later US patents
- In vitro transcription methods and constructs87US 10,465,190 B1ModernaTX, Inc. · 2019
- Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus41US 6,660,521 B2GenVec, Inc. · 2003
- Recombinant production of authentic human proteins using human cell expression systems22US 8,236,527 B2Humanzyme Limited · 2012
- Translation of m-RNA18US 5,489,527 ADiatech, Inc. · 1996
- Circular RNA for translation in eukaryotic cells16US 11,203,767 B2Massachusetts Institute of Technology · 2021